<SEC-DOCUMENT>0001558370-22-018970-index.html : 20221223 <SEC-HEADER>0001558370-22-018970.hdr.sgml : 20221223 <ACCEPTANCE-DATETIME>20221223160907 ACCESSION NUMBER: 0001558370-22-018970 CONFORMED SUBMISSION TYPE: PRE 14A PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20230208 FILED AS OF DATE: 20221223 DATE AS OF CHANGE: 20221223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: PRE 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 221485465 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>PRE 14A <SEQUENCE>1 <FILENAME>tmb-20230208xpre14a.htm <DESCRIPTION>PRE 14A <TEXT> Document 1 - file: tmb-20230208xpre14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>tmb-20230208xpre14a005.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: tmb-20230208xpre14a005.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>tmb-20230208xpre14a006.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: tmb-20230208xpre14a006.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>tmb-20230208xpre14a001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: tmb-20230208xpre14a001.jpg
</DOCUMENT> </SEC-DOCUMENT>